October 03, 2018 Few biopharma buyouts in quiet third quarter The $6.6bn of M&A deals announced by drug makers in third quarter of 2018 marks the slowest three-month period since 2013.
August 31, 2018 Working for the government proves extremely profitable for Emergent With its latest acquisition Emergent Biosolutions is tapping into new ways to access public spending.
